in

Ozempic Vs Mounjaro: Semaglutide Vs. Tirzepatide

Ozempic Vs Mounjaro

Ozempic Vs Mounjaro is a comparison of two weekly diabetes medicines, Semalgutide and Tirzepatide.

Both these drugs are compared and presented here in a table format for easy understanding.


Ozempic Vs Mounjaro: Basics


 

Ozempic

Mounjaro

ClassGLP-1 analogDual GLP-1 and GIP analog
DrugSemaglutideTirzepatide
ManufacturerNovo NordiskEli Lilly
Uses (Approved Indication)Diabetes Type 2Diabetes Type 2

Both Ozempic and Mounjaro have got approval from the FDA for the treatment of Diabetes Type 2. Semaglutide has also been approved for oral use by the brand name Rybelsus.

Rybelsus is also approved only for the treatment of Type 2 Diabetes. It is taken as a once-daily oral tablet alone or in combination with Jardiance, Farxiga, Metformin, Insulin, or sulfonylurea.

Wegovy is a once-weekly high-dose Semaglutide that has been approved only for the treatment of obesity and weight loss.

 


Ozempic Vs Mounjaro: Dosing


Dosage and Formulations

Ozempic

Mounjaro

Formulation0.5 ml pen injector that contains:
  • 0.25 mg/ 0.5 ml
  • 0.5 mg/0.5 ml
  • 1 mg/0.5 ml
0.5 ml pen injector that contains:
  • 2.5 mg/ 0.5 ml
  • 5 mg/0.5 ml
  • 7.5 mg/0.5 ml
  • 10 mg/0.5 ml
  • 12.5 mg/0.5 ml
  • 15 mg/0.5 ml
Dose0.25 mg once weekly for 4 weeks, then 0.5 mg once weekly for 4 weeks or continued.

After 4 weeks, the dose may be increased to 1 mg per week for 4 weeks up to 2 mg per week

2.5 mg once weekly for 4 weeks, then 5 mg once weekly for 4 weeks or continued.

After 4 weeks, the dose may be increased at monthly intervals to 7.5 mg, 10 mg, 12.5 mg, and then 15 mg per week maximum

How to administerSubcutaneous in the skinSubcutaneous in the skin

Both Ozempic and Mounjaro are administered once weekly into the skin. Both these drugs are given in a low dose for four weeks after which the dose is increased.

The maximum dose of Ozempic, as per the manufacturer’s labeling is 1 mg weekly. However, recently the maximum dose has been increased to 2 mg once weekly for the treatment of Diabetes Mellitus.

Mounjaro (Tirzepatide) is administered as a 2.5 mg injection weekly for four weeks. The dose is then increased to 5 mg which is the usual starting anti-diabetic dose.

The maximum recommended dose of Mounjaro is 15 mg once a week.

 


Ozempic Vs Mounjaro: A1C and Weight Loss

Efficacy

Ozempic

Mounjaro

A1C reduction
  • 0.5 mg: 1.5%
  • 1 mg: 1.86%
  • 5 mg: 2.01%
  • 10 mg: 2.24%
  • 15 mg: 2.30%
Weight Loss
  • 0.5 mg: 4.6 kg
  • 1 mg: 5.7 kgs – 6.5 kgs
  • 5 mg: 7.6 kgs
  • 10 mg: 9.3 kgs
  • 15 mg: 11.2 kgs

Ozempic vs Mounjaro for Diabetes: Effect on A1C:

Both Ozempic and Mounjaro are two highly potent diabetes medications. These drugs have shown superior efficacies in the management of diabetes compared to all the currently available diabetes medications.

When comparing Ozempic with Mounjaro, both 0.5 mg and 1 mg Ozempic have comparable A1C-lowering effects vs low-dose Mounjaro in a dose of 5 mg once weekly.

Mounjaro in a dose of 10 mg and 15 mg weekly, however, demonstrated superiority over Ozempic 0.5 mg and 1 mg administered once a week.

The mean difference in A1C between Ozempic and Mounjaro

Ozempic dose

Mounjaro dose

Which is better

0.51%0.5 mg5 mgMounjaro
0.15%1 mg5 mgComparable
0.74%0.5 mg10 mgMounjaro
0.38%1 mg10 mgMounjaro
0.8%0.5 mg15 mgMounjaro
0.44%1 mg15 mgMounjaro

Ozempic Vs Mounjaro for Diabetes: Effect on Body Weight:

Among the six weight loss medicines that have been approved, Semaglutide has shown superior results. However, the low-dose formulation, Ozempic is not approved for weight loss.

The FDA approved Tirzepatide on 8th November, 2023 for weight loss but with a different brand name, Zepbound.

Since both Ozempic and Mounjaro are associated with significant weight loss, we compared the weight loss effects of both these drugs.

Ozempic in a dose of 0.5 mg is associated with about 4.6 kg of weight loss while 1 mg is associated with 5.7 to 6.5 kg of weight loss.

On the other hand, the weight loss effect of 15 mg Mounjaro is double that of Ozempic 1 mg.

High dose Semaglutide, Wegovy has been associated with a maximum weight loss of 16% while Mounjaro is associated with 22% body weight loss.

Drug

Dose

Weight Loss

Ozempic0.5 mg4.6 kg
1 mg5.7 – 6.5 kg
Mounjaro5 mg7.6 kg
10 mg9.3 kg
15 mg11.2 kg

Mounjaro is associated with greater weight loss even in low doses compared to high-dose Ozempic.


Ozempic Vs Mounjaro Side Effects

Side effects

Ozempic

Mounjaro

Contraindications
  • Allergic reactions
  • MEN II syndrome
  • Medullary thyroid carcinoma
  • Allergic reactions
  • MEN II syndrome
  • Medullary thyroid carcinoma
Pancreatitis0.3 cases per 100 patient-years (vs 0.2 cases in the comparator group)0.23 cases per 100 years of exposure (vs 0.11 cases per 100 years of exposure in the comparator group
Diabetic RetinopathyWith background disease: 3% vs 1.8 % in the placebo

Without background disease: 8.2% vs 5.2% in the placebo

Hypoglycemia
  • 0.5 mg: 16.7%
  • 1 mg: 29.8%

vs 15.2% in the placebo

  • 5 mg: 16%
  • 10 mg: 19%
  • 15 mg: 14%

Vs 13% in the placebo

Acute renal failureCan cause acute renal failureCan cause acute renal failure
Nausea
  • 0.5 mg: 15.8%
  • 1 mg: 20.3%
  • 5 mg: 12%
  • 10 mg: 15%
  • 15 mg: 18%
Vomiting
  • 0.5 mg: 5%
  • 1 mg: 9.2%
  • 5 mg: 5%
  • 10 mg: 5%
  • 15 mg: 9%
Diarrhea
  • 0.5 mg: 8.5%
  • 1 mg: 8.8%
  • 5 mg: 12%
  • 10 mg: 13%
  • 15 mg: 17%
Abdominal pain
  • 0.5 mg: 7.3%
  • 1 mg: 5.7%
  • 5 mg: 6%
  • 10 mg: 6%
  • 15 mg: 5%
Constipation
  • 0.5 mg: 5%
  • 1 mg: 3.1%
  • 5 mg: 6%
  • 10 mg: 6%
  • 15 mg: 7%
Gallstones
  • 0.5 mg: 1.5%
  • 1 mg: 0.4%
0.6%
Amylase13%38%
Lipase22%42%
Injection site reaction0.2%3.2%
Fatigue0.4%
Heart rate2 – 3 beats per minute2 – 4 beats per minute

The side effects of both Ozempic and Mounjaro are comparable. Since both these drugs have a similar mechanism of action and both are incretins, both these drugs can cause pancreatitis.

The incidence of medullary thyroid cancer is not well known but both these drugs should not be given to individuals who have a history of medullary thyroid cancer or MEN-II syndrome.

 

In summary:

Ozempic and Mounjaro are highly potent drugs used in the treatment of diabetes mellitus. They have significant weight loss effects and lower the A1C significantly.

Mounjaro has superior A1C-lowering effects and is associated with greater weight loss compared to Ozempic.

  • 97% Pure Berberine Powder – High-purity, plant-derived extract with a rich yellow color. Carefully processed and lab-tes…
  • Naturally Bitter Taste – Berberine has a strong, naturally bitter flavor. Best enjoyed when mixed with smoothies, tea, c…
  • 100g in Resealable Foil Pouch – Packaged in a premium aluminum pouch to protect from moisture and light, keeping the pow…
  • 5 Delicious Flavors: Freeze-Dried Mango, Freeze-Dried Blueberry, Freeze-Dried Orange, Freeze-Dried Dragon Fruit & Freeze…
  • Pure and Natural Ingredients: Our fruit powders are made without synthetic pesticides, GMOs, or harmful chemicals. Each …
  • Health Benefits: Our carefully selected fruits are packed with antioxidants, vitamins, fiber, and digestive enzymes to s…
  • 🌿 4 Tangy Citrus Flavors in One Pack: Enjoy a delicious variety of Orange, Lime, Lemon, and Kiwi powder – 5 sachets of e…
  • 💧Easy to Mix & Refreshing: Just add to water, smoothies, sparkling drinks, or tea for a vibrant citrus kick. Dissolves i…
  • 🛡️Rich in Vitamin C & Antioxidants: Made from real fruit powders, this mix offers a natural source of vitamin C to suppo…
  • VARIETY PACK – Includes 5 delicious organic berry powder flavors: Freeze-Dried Goji Berry, Freeze-Dried Strawberry, Free…
  • PURE INGREDIENTS – Made with 100% natural, freeze-dried berries and absolutely no added sugar, artificial ingredients, o…
  • CONVENIENT PACKAGING – Contains 20 pre-portioned 5g packets (100g total), eliminating the need for measuring and ensurin…

What do you think?

Written by Dr. Ahmed

MBBS, FCPS (Medicine) | Assistant Professor of Medicine
Internal Medicine Specialist | Chronic Disease & Wellness Expert | Medical Writer

I am Dr. Ahmed Farhan, a board-certified Internist with over 15 years of clinical experience at Pakistan Institute of Medical Sciences, Islamabad, one of the busiest tertiary-care hospitals in Pakistan. I specialize in chronic disease management, diabetes care, obesity treatment, nutrition, and lifestyle medicine.

For the past 6–7 years, I’ve been writing evidence-based health articles on Dibesity.com and Emedz.net, helping thousands of readers make informed decisions about their health.

My medical writing follows international standards (ICMJE), and I ensure every article is:

Scientifically accurate
Up-to-date with the latest guidelines & research
Easy to understand for patients and families

Outside of medicine, I enjoy morning walks, hiking, nature, and spending quality time with my three daughters.

📌 Learn more about my qualifications and background → About Me
📌 Connect With Me:

Facebook Page: Link
Email: contact@dibesity.com
Twitter/X: Link
WhatsApp (For queries): Link 🙏

Mediterranean Diet for Prediabetes

Mediterranean Diet for Prediabetes

lung cancer treatment signs and symptoms of pancreatic cancer

Signs And Symptoms Of Pancreatic Cancer